(Q48299257)

10 February 2018

title

The prevalence and clinical characteristics of MS in northern Japan. (English)

1 reference

10 February 2018

3

Seiji Kikuchi

1 reference

10 February 2018

author name string

Hideki Houzen

1

1 reference

10 February 2018

Masaaki Niino

2

1 reference

10 February 2018

Toshiyuki Fukazawa

4

1 reference

10 February 2018

Shinji Nogoshi

5

1 reference

10 February 2018

Hiroyuki Matsumoto

6

1 reference

10 February 2018

Kunio Tashiro

7

1 reference

10 February 2018

publication date

1 July 2003

1 reference

10 February 2018

Journal of the Neurological Sciences

published in

1 reference

10 February 2018

volume

211

1 reference

10 February 2018

page(s)

49-53

1 reference

10 February 2018

issue

1-2

1 reference

10 February 2018

The virology of demyelinating diseases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

The prevalence of multiple sclerosis in the world: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

Clinical studies of multiple sclerosis in Japan: classical multiple sclerosis and Devic's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

Nationwide survey of multiple sclerosis in Japan Clinical analysis of 1,084 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

Multiple Sclerosis in Hokkaido, the Northernmost Island of Japan. Prospective Analyses of Clinical Features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

Multiple sclerosis amongst Chinese in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

Multiple sclerosis among Orientals and Caucasians in Hawaii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

Geography in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

Genetic epidemiology of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

Changes in the clinical phenotypes of multiple sclerosis during the past 50 years in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

Multiple Sclerosis and Allied Diseases in Japan: Epidemiological and Clinical Aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Multiple sclerosis in Asia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2803%2900033-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(03)00033-9

1 reference

10 February 2018

PubMed ID

12767497

1 reference

10 February 2018